Chronic Macrocytic Anemia: 8 Causes and How It’s Treated

·

Share

Chronic macrocytic anemia is a long-standing low hemoglobin in which the red blood cells are larger than normal, with a mean corpuscular volume (MCV) above about 100 fL. It is a sign, not a final diagnosis. The most common causes are vitamin B12 or folate deficiency, alcohol, liver disease, an underactive thyroid, certain medicines, and bone marrow disorders such as myelodysplastic syndromes. Finding which one is responsible decides the treatment, and in B12 deficiency, prompt treatment can prevent permanent nerve damage.

What Is Macrocytic Anemia?

Anemia means a low hemoglobin, the oxygen-carrying protein in red cells. Macrocytic means the cells are larger than normal red blood cells, which have an MCV of roughly 80 to 100 fL. Large cells arise when the bone marrow cannot copy DNA properly, or when the cell membrane or maturation process is disturbed.

Hematologists split macrocytic anemia into two groups, because the split narrows the causes quickly:

  • Megaloblastic: DNA synthesis is impaired, so developing cells in the marrow grow large while their nuclei lag behind. B12 deficiency, folate deficiency, and some drugs cause this.
  • Non-megaloblastic: DNA synthesis is normal, but the cells are large for other reasons, such as alcohol, liver disease, hypothyroidism, myelodysplastic syndromes, or a high number of young red cells (reticulocytes).

Causes and Risk Factors

Cause Type Typical clues
Vitamin B12 deficiency (including pernicious anemia) Megaloblastic Numbness, tingling, poor balance, memory changes; vegan diet, gastric surgery, metformin use
Folate deficiency Megaloblastic Poor diet, heavy alcohol use, pregnancy, malabsorption
Drugs (methotrexate, hydroxyurea, azathioprine, some antiretrovirals and anticonvulsants) Often megaloblastic Macrocytosis appears after starting the medicine
Alcohol Non-megaloblastic MCV often mildly raised even without anemia
Liver disease Non-megaloblastic Abnormal liver tests, target cells on the smear
Hypothyroidism Non-megaloblastic Fatigue, weight gain, cold intolerance
Myelodysplastic syndromes (MDS) Non-megaloblastic Older age, other low counts, abnormal cells on the smear
Reticulocytosis Non-megaloblastic Recovery from bleeding or hemolysis

Pernicious anemia deserves special mention. It is an autoimmune condition that destroys the stomach cells making intrinsic factor, the protein needed to absorb B12. It is a common cause of B12 deficiency in older adults and needs lifelong treatment.

People at higher risk of a deficiency-related macrocytic anemia include older adults, strict vegans who do not take a B12 supplement, people who have had weight-loss or other stomach surgery, and those with celiac disease or Crohn’s disease affecting the small bowel. Long-term use of metformin or acid-suppressing medicines can also lower B12 levels gradually. In my practice, these groups are where a simple B12 check most often turns up a treatable cause that had been missed for years.

Cancer treatment is another frequent setting. Several chemotherapy agents cause macrocytosis, and anemia during treatment is often multifactorial, as discussed in our article on chemo-induced anemia and its ICD-10 classification.

Signs and Symptoms

Because the anemia develops slowly, many people adapt and notice only gradual tiredness. General anemia symptoms include fatigue, pale or slightly yellow skin, breathlessness on exertion, palpitations, and headaches.

Some features point toward a particular cause:

  • B12 deficiency: pins and needles in the feet and hands, unsteadiness, a smooth sore tongue, low mood, and memory problems. Nerve symptoms can occur even when the anemia is mild or absent.
  • Liver disease: jaundice, swelling of the abdomen, easy bruising.
  • MDS: infections or bruising from low white cells or platelets alongside the anemia.

How Chronic Macrocytic Anemia Is Diagnosed

The first clue usually comes from a routine complete blood count showing a raised MCV. A step-by-step workup follows.

  1. Review of medicines and alcohol intake, since both are common and easily fixed.
  2. Reticulocyte count to see whether the marrow is responding to blood loss or hemolysis.
  3. Blood smear: oval macrocytes and hypersegmented neutrophils (white cells with six or more nuclear lobes) suggest a megaloblastic cause.
  4. Vitamin B12 and folate levels. When B12 results are borderline, methylmalonic acid and homocysteine help; both rise in B12 deficiency, while only homocysteine rises in folate deficiency.
  5. Intrinsic factor antibodies if pernicious anemia is suspected.
  6. Thyroid and liver function tests.
  7. Bone marrow biopsy if the cause remains unclear, especially in older adults or when other blood counts are also low, to look for MDS.

A Note on ICD-10 Coding

Macrocytic anemia is best coded by its cause. In ICD-10-CM, pernicious anemia is D51.0, other B12 deficiency anemias fall under D51, folate deficiency anemias under D52, and other megaloblastic anemias not elsewhere classified under D53.1. MDS is coded in the D46 group, and anemia due to antineoplastic chemotherapy is D64.81. Coders should confirm the final code against the current code set and the clinical documentation.

Treatment and Management

Treatment targets the cause. The raised MCV itself is not treated.

  • B12 deficiency: vitamin B12 injections, usually given frequently at first and then at maintenance intervals. High-dose oral B12 is an option for many people without severe neurological symptoms. Pernicious anemia requires treatment for life.
  • Folate deficiency: oral folic acid, typically for several months, plus attention to diet. B12 deficiency must be excluded or treated first, because folic acid alone can improve the blood count while nerve damage from B12 deficiency progresses.
  • Drug-related macrocytosis: often expected and harmless, as with hydroxyurea; the prescribing doctor decides whether any change is needed.
  • Alcohol and liver disease: reducing or stopping alcohol and treating the liver condition, with nutritional support.
  • Hypothyroidism: thyroid hormone replacement; the MCV normalizes gradually.
  • MDS: specialist care, ranging from monitoring and transfusion support to erythropoiesis-stimulating agents, lenalidomide for certain genetic subtypes, or disease-modifying therapy.

With B12 or folate replacement, the reticulocyte count rises within about a week and hemoglobin usually recovers over several weeks. Nerve symptoms improve more slowly and may not fully resolve if they have been present for a long time.

When to See a Doctor

See a doctor if you have persistent tiredness, pallor, or a blood test showing a high MCV. Seek prompt care for numbness, tingling, unsteady walking, or confusion, because B12-related nerve damage is time-sensitive. Fever, frequent infections, or unexplained bruising alongside anemia also warrant urgent assessment. For related conditions, see our overview of blood disorders and our anemia guide.

Frequently Asked Questions

Is a high MCV without anemia a problem?

Macrocytosis without anemia is common and often due to alcohol, medicines, or early B12 or folate deficiency. It is worth investigating, because it can be the first sign of a treatable deficiency before anemia develops.

Can chronic macrocytic anemia be cured?

Many causes are fully reversible, including folate deficiency, drug effects, and hypothyroidism. Pernicious anemia is controlled rather than cured and needs lifelong B12, while MDS requires ongoing specialist management.

Should I take folic acid if I have large red blood cells?

Not without testing. Taking folic acid when the real problem is B12 deficiency can mask the anemia while nerve damage continues. Check both levels first.

How long do B12 injections take to work?

Many people feel more energetic within days to a couple of weeks, and blood counts typically normalize within about two months. Nerve symptoms may take months to improve.

Written by
Haematology, Platelet Biology
Contact TF_Birkle Website Bloodworks Northwest/University of Washington September 1, 2020 Targeting Undruggable Fusions in AML The Johnsen Lab studies the genetics and biology of clotting factors and blood groups, with emphasis on factor VIII (FVIII), factor IX (FIX), von Willebrand factor (VWF), and clinically relevant blood group genes in ABO and Rh. Dr. Johnsen is further interested in how inherited…
View Full Profile →
Web Admin Avatar